1 Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci, 2008, 121(Suppl 1): 1–84
[2]
2 Rowley J D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973, 243: 290–293
[3]
3 Tabin C J, Bradley S M, Bargmann C I, et al. Mechanism of activation of a human oncogene. Nature 1982, 300: 143–149
[4]
4 Reddy E P, Reynolds R K, Santos E, et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature, 1982, 300: 149–152
[5]
5 Hanahan D, Weinberg R A. The hallmarks of cancer. Cell, 2000, 100: 57–70
[6]
6 Hanahan D, Weinberg R A. Hallmarks of cancer: The next generation. Cell, 2011, 144: 646–674
[7]
14 Rubin A F, Green P. Mutation patterns in cancer genomes. Proc Natl Acad Sci USA, 2009, 106: 21766–21770
[8]
15 Rodrigue S, Malmstrom R R, Berlin A M, et al. Whole genome amplification and de novo assembly of single bacterial cells. PLoS One, 2009, 4: e6864
[9]
16 Druley T E, Vallania F L, Wegner D J, et al. Quantification of rare allelic variants from pooled genomic DNA. Nat Methods, 2009, 6: 263–265
[10]
17 Albert T J, Molla M N, Muzny D M, et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods, 2007, 4: 903–905
[11]
18 Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol, 2009, 27: 182–189
[12]
19 Hodges E, Xuan Z, Balija V, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet, 2007, 39: 1522–1527
[13]
20 Turner E H, Lee C, Ng S B, et al. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat Methods, 2009, 6: 315–316
[14]
21 Levin J Z, Berger M F, Adiconis X, et al. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol, 2009, 10: R115
[15]
22 Palanisamy N, Ateeq B, Kalyana-Sundaram S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med, 2010, 16: 793–798
[16]
23 Shah S P, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med, 2009, 360: 2719–2729
[17]
24 Paz N, Levanon E Y, Amariglio N, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res, 2007, 17: 1586–1595
[18]
43 Guo G, Sun X, Chen C, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet, 2013, 45: 1459–1463
[19]
44 Wu S, Lv Z, Zhu J, et al. Somatic mutation of the androgen receptor gene is not associated with transitional cell carcinoma: A “negative” study by whole-exome sequencing analysis. Eur Urol, 2013, 64: 1018–1019
[20]
45 Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature, 2014, 509: 91–95
[21]
46 Gao Y B, Chen Z L, Li J G, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet, 2014, 46: 1097–1102
[22]
47 Lin D C, Hao J J, Nagata Y, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet, 2014, 46: 467–473
[23]
48 Huang J, Deng Q, Wang Q, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet, 2012, 44: 1117–1121
[24]
49 Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet, 2011, 43: 828–829
[25]
50 Sung W K, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 2012, 44: 765–769
[26]
51 Kan Z, Zheng H, Liu X, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res, 2013, 23: 1422–1433
[27]
52 Tao Y, Ruan J, Yeh S H, et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci USA, 2011, 108: 12042–12047
[28]
53 Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 2011, 19: 232–243
[29]
7 Dulbecco R. A turning point in cancer research: Sequencing the human genome. Science, 1986, 231: 1055–1056
[30]
8 Lander E S, Linton L M, Birren B, et al. Initial sequencing and analysis of the human genome. Nature, 2001, 409: 860–921
[31]
9 Venter J C, Adams M D, Myers E W, et al. The sequence of the human genome. Science, 2001, 291: 1304–1351
[32]
10 International Human Genome Sequencing C. Finishing the euchromatic sequence of the human genome. Nature, 2004, 431: 931–945
[33]
11 Garraway L A, Lander E S. Lessons from the cancer genome. Cell, 2013, 153: 17–37
[34]
12 Schweiger M R, Kerick M, Timmermann B, et al. Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One, 2009, 4: e5548
[35]
13 Pinard R, De Winter A, Sarkis G J, et al. Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing. BMC Genomics, 2006, 7: 216
[36]
25 International Cancer Genome C. International network of cancer genome projects. Nature, 2010, 464: 993–998
[37]
26 Toronto International Data Release Workshop A. Prepublication data sharing. Nature, 2009, 461: 168–170
[38]
27 Haider S, Ballester B, Smedley D, et al. BioMart Central Portal—unified access to biological data. Nucleic Acids Res, 2009, 37: W23–W27
[39]
28 Nik-Zainal S, Alexandrov L B, Wedge D C, et al. Mutational processes molding the genomes of 21 breast cancers. Cell, 2012, 149: 979–993
[40]
29 Nik-Zainal S, van Loo P, Wedge D C, et al. The life history of 21 breast cancers. Cell, 2012, 149: 994–1007
[41]
30 Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med, 2011, 365: 1384–1395
[42]
31 Malcovati L, Papaemmanuil E, Bowen D T, et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood, 2011, 118: 6239–6246
[43]
32 Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood, 2013, 122: 3616–3627, quiz 3699
[44]
33 India Project Team of the International Cancer Genome C. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun, 2013, 4: 2873
[45]
34 Jones D T, Hutter B, Jager N, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet, 2013, 45: 927–932
[46]
35 Tirode F, Surdez D, Ma X, et al. Genomic landscape of ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov, 2014, 4: 1342–1353
[47]
36 Dove E S, Joly Y, Tasse A M, et al. Genomic cloud computing: Legal and ethical points to consider. Eur J Hum Genet, 2014, doi: 10.1038/ejhg.2014.196
[48]
37 Gonzalez-Perez A, Mustonen V, Reva B, et al. Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods, 2013, 10: 723–729
[49]
38 Wong C C, Martincorena I, Rust A G, et al. Inactivating CUX1 mutations promote tumorigenesis. Nat Genet, 2014, 46: 33–38
[50]
39 Yan X J, Xu J, Gu Z H, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet, 2011, 43: 309–315
[51]
40 Cao Y, Gao Z, Li L, et al. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun, 2013, 4: 2810
[52]
41 Cao Y, He M, Gao Z, et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome. Science, 2014, 344: 913–917
[53]
42 Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet, 2011, 43: 875–878
